| 000 | 01386 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518002759.0 | ||
| 264 | 0 | _c20190205 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1757-790X | ||
| 024 | 7 |
_a10.1136/bcr-2018-227144 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPipa, Sara | |
| 245 | 0 | 0 |
_aScleromyxoedema: the importance of physical examination. _h[electronic resource] |
| 260 |
_bBMJ case reports _cOct 2018 |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiopsy _xmethods |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 |
_aFibroblasts _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMucins _xmetabolism |
| 650 | 0 | 4 |
_aPolychondritis, Relapsing _xdiagnosis |
| 650 | 0 | 4 |
_aScleromyxedema _xdiagnosis |
| 650 | 0 | 4 |
_aSkin _ximmunology |
| 650 | 0 | 4 |
_aThalidomide _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSá, Juliana | |
| 700 | 1 | _aMondragão, Ana | |
| 700 | 1 | _aMarinho, António | |
| 773 | 0 |
_tBMJ case reports _gvol. 2018 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bcr-2018-227144 _zAvailable from publisher's website |
| 999 |
_c28935221 _d28935221 |
||